• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home Career Development

Tranexamic acid reduces life-threatening postpartum bleeding

byNeel MistryandTeddy Guo
December 10, 2024
in Career Development, Emergency, ENT, Obstetrics, Pharma
Reading Time: 2 mins read
Amniotic fluid lactate associated with labor disorders
Share on FacebookShare on Twitter

1. Tranexamic acid significantly reduced life-threatening postpartum bleeding.

2. There were no differences in the risk of thromboembolic events.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Postpartum hemorrhage is a significant cause of maternal mortality. While tranexamic acid is used to treat this condition, its potential to prevent bleeding remains unclear. This systematic review and meta-analysis aimed to examine tranexamic acid’s effects in reducing life-threatening bleeding and thromboembolic risk in women giving birth. The primary outcome of this study was the number of women with life-threatening bleeding, while a key secondary outcome was the incidence of thromboembolic events. According to study results, tranexamic acid significantly lowered the risk of life-threatening bleeding compared to placebo. Although this study was well done, it was limited by its focus on a specific subset of large, low-bias trials, which may not fully represent outcomes in broader populations.

Click to read the study in The Lancet

Relevant Reading: Tranexamic Acid in Patients Undergoing Noncardiac Surgery

RELATED REPORTS

2 Minute Medicine Rewind Aug 24th, 2026 

A health coaching intervention may improve blood pressure control in postpartum women

2 Minute Medicine Rewind August 10, 2026

In-depth [systematic review and meta-analysis]: Randomized trials assessing the effects of tranexamic acid in women giving birth were assessed from databased inception to Aug 4, 2024. Included were those that were prospectively registered, placebo-controlled, involving > 500 patients, and having low bias risk. Altogether, 54 404 women were included in the final analysis. The primary outcome showed that tranexamic acid significantly reduced the rate of life-threatening postpartum bleeding compared to placebo (178 vs. 230, odds ratio [OR] 0.77, 95% confidence interval [CI] 0.63-0.93, p=0.008). The secondary outcome of thromboembolic events found no significant difference between groups (50 vs. 52, OR 0.96, 95% CI 0.65-1.41, p=0.82). Findings from this study suggest that tranexamic acid is effective in preventing severe bleeding in childbirth without increasing thromboembolic risks.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: obstetricspostpartum bleedingpostpartum hemorrhagepregnancyTranexamic acidTXA
Previous Post

Invasive treatment not superior to medical therapy in older adults with NSTEMI

Next Post

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

RelatedReports

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Weekly Rewinds

2 Minute Medicine Rewind Aug 24th, 2026 

August 26, 2026
Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

A health coaching intervention may improve blood pressure control in postpartum women

August 12, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

Medical or procedural abortion may not increase risk of psychotropic medication use after five years

July 27, 2026
Next Post
USPSTF recommends chemoprevention for women at high risk for breast cancer

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons

#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons

Maternal cell-free DNA sequencing superior to standard aneuploidy screening [CARE Study]

Australian couple-based genetic screening program feasible and accepted

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deficits in executive function are not universal among patients with alcohol use disorder
  • Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear
  • Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.